Selective Wealth Management, Inc. Vertex Pharmaceuticals Inc Transaction History

Selective Wealth Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	BUY	$221.42 - $260.97 $2,214 - $2,609	10 Added 11.11%	100 $26,000
Q4 2021 Jan 18, 2022	SELL	$177.01 - $223.45 $17,701 - $22,345	-100 Reduced 52.63%	90 $20,000
Q2 2021 Aug 04, 2021	BUY	$187.49 - $221.1 $7,499 - $8,844	40 Added 26.67%	190 $38,000
Q1 2021 Apr 09, 2021	BUY	$207.02 - $241.31 $10,351 - $12,065	50 Added 50.0%	150 $32,000
Q3 2019 Oct 29, 2019	BUY	$166.23 - $187.09 $16,623 - $18,709	100 New	100 $17,000
Q1 2019 Apr 04, 2019	SELL	$163.73 - $194.7 $16,372 - $19,470	-100 Closed	0 $0
Q3 2018 Oct 12, 2018	BUY	$167.73 - $192.74 $16,773 - $19,274	100 New	100 $19,000

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Selective Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Selective Wealth Management, Inc. with notifications on news.